Last reviewed · How we verify

NCT03276364

The Impact of Point-of-Care Ultrasound

Completed Last updated 8 September 2017
What this trial tests

trial testing Ultrasound in Ultrasound in 112 participants. Completed in 17 April 2015.

Timeline
21 July 2014
Primary endpoint
17 April 2015
17 April 2015

Quick facts

Lead sponsorMontefiore Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment112
Start date21 July 2014
Primary completion17 April 2015
Estimated completion17 April 2015

Drugs / interventions tested

Conditions studied

Sponsor

Montefiore Medical Center

Who can join

18 and older, any sex, with Ultrasound or Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Point-of-care ultrasound (POCUS) has been found to be useful for aiding in the prediction of fluid responsiveness. It is unknown if trainees can effectively utilize this tool to improve their assessment of fluid responsiveness. In this prospective, observational study, pulmonary and critical care fellows are asked to make 2 assessments of fluid responsiveness in adults with shock: (1) based on clinical exam alone (Clinical) and (2) after performing a POCUS (Clinical + US). The accuracy of their pre- and post-ultrasound assessments are compared using a bioreactance monitor and passive leg raise test as the gold standard of fluid responsiveness in this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Ultrasound

Currently open trials in the same condition.

Other Montefiore Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03276364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing